Buyung Poetra Sembada Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Buyung Poetra Sembada Tbk. trades at Rp53 (market cap 512.92B, 13.99M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Buyung Poetra Sembada Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and Buyung Poetra Sembada Tbk. is more actively traded (13.99M versus 817.3K). Which is the better fit depends on your goals.
| HOKI | LABS | |
|---|---|---|
Market Cap | 512.92B | 584.6B |
Volume | 13.99M | 817.3K |
Lot | 139.91K | 8.17K |
Turnover | 739.37M | 120.01M |
Average Price | 52.85 | 146.84 |
Value | 739.37M | 120.01M |
Indicative Equilibrium Price | 53 | 146 |
Indicative Equilibrium Volume | 1.35K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Buyung Poetra Sembada Tbk (the “Company”) was established based on Notarial Deed No. 46 ofIchsan Tedjabuana, S.H., dated September 16, 2003.
Read more on HOKI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →